Pages that link to "Item:Q2219723"

The following pages link to Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy (Q2219723):

Displaying 40 items.

• Feasibility of parameter estimation in hepatitis C viral dynamics models (Q511035) (← links)
• Global properties for virus dynamics model with mitotic transmission and intracellular delay (Q542870) (← links)
• vRNA structured population model for Hepatitis C virus dynamics (Q738183) (← links)
• Hopf bifurcation and stability switches induced by humoral immune delay in hepatitis C (Q828950) (← links)
• Global dynamics of a delayed within-host viral infection model with both virus-to-cell and cell-to-cell transmissions (Q899419) (← links)
• Chronic hepatitis B infection and HBV DNA-containing capsids: modeling and analysis (Q907619) (← links)
• Evaluating treatment of hepatitis C for hemolytic anemia management (Q975959) (← links)
• Stability and Hopf bifurcation in a delayed viral infection model with mitosis transmission (Q1636851) (← links)
• Global analysis of a mathematical model for hepatitis C considering the host immune system (Q1706549) (← links)
• Nonlinear Kalman filtering for censored observations (Q1740241) (← links)
• Modelling hepatitis C virus infection and the development of hepatocellular carcinoma (Q1784752) (← links)
• Influence of intracellular delay on the dynamics of Hepatitis C virus (Q1794656) (← links)
• Analysis of hepatitis C viral dynamics using Latin hypercube sampling (Q1948250) (← links)
• Effect of DAA therapy in hepatitis C treatment -- an impulsive control approach (Q1981065) (← links)
• On an age-structured hepatitis B virus infection model with HBV DNA-containing capsids (Q2021591) (← links)
• Threshold dynamics of a general delayed within-host viral infection model with humoral immunity and two modes of virus transmission (Q2033769) (← links)
• Modeling the cell-to-cell transmission dynamics of viral infection under the exposure of non-cytolytic cure (Q2053191) (← links)
• Analysis of a reaction-diffusion HCV model with general cell-to-cell incidence function incorporating B cell activation and cure rate (Q2060301) (← links)
• Analysis of a stochastic HBV infection model with delayed immune response (Q2091983) (← links)
• Machine learning for mathematical models of HCV kinetics during antiviral therapy (Q2118485) (← links)
• Global dynamics analysis of a time-delayed dynamic model of Kawasaki disease pathogenesis (Q2120343) (← links)
• Stochastic viral infection model with lytic and nonlytic immune responses driven by Lévy noise (Q2164937) (← links)
• Stochastic analysis of in-host HCV dynamics through budding and bursting process (Q2205386) (← links)
• Threshold dynamics of HCV model with cell-to-cell transmission and a non-cytolytic cure in the presence of humoral immunity (Q2207871) (← links)
• Modeling the effect of non-cytolytic immune response on viral infection dynamics in the presence of humoral immunity (Q2296898) (← links)
• Dynamical analysis on a chronic hepatitis C virus infection model with immune response (Q2351364) (← links)
• Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin (Q2437016) (← links)
• Analysis of a stochastic HBV infection model with DNA-containing capsids and virions (Q2677647) (← links)
• Viral dynamics with immune responses: effects of distributed delays and Filippov antiretroviral therapy (Q2684036) (← links)
• Dynamics of Hepatitis C Virus Infection: Mathematical Modeling and Parameter Estimation (Q4607581) (← links)
• Some stability results for a model of Hepatitis C including alanine aminotransferase and immune system (Q4984989) (← links)
• (Q5021866) (← links)
• Sensitivity analysis of chronic hepatitis C virus infection with immune response and cell proliferation (Q5110332) (← links)
• Global dynamics for a live-virus-blood model with distributed time delay (Q5346053) (← links)
• THE IMPACT OF NONSINGULAR MEMORY ON THE MATHEMATICAL MODEL OF HEPATITIS C VIRUS (Q6114657) (← links)
• Viral rebound occurrence immediately after drug discontinuation involving neither drug resistance nor latent reservoir (Q6130757) (← links)
• Some sufficient conditions for global asymptotic stability of a hepatitis C virus mathematical model considering host immune system (Q6142136) (← links)
• Dynamics analysis of a diffusional immunosuppressive infection model with Beddington-DeAngelis functional response (Q6153148) (← links)
• Insights into unexpected relapse and recovery in HCV-infected patients by studying a stochastic within-host HCV model (Q6181267) (← links)
• Observer‐based controller for treatment of hepatitis C infection using fractional order model (Q6189714) (← links)